Florida

Florida Governor Ron DeSantis (R) signed into law on June 20, 2022, House Bill 357 which requires a health insurer or health maintenance organization providing pharmacy benefits through a group health insurance policy, including a pharmacy benefit manager, must comply with audit requirements. In addition, the legislation provides a penalty for failure to register as a pharmacy benefit manager. The law takes effect July 1, 2022.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-06-24T12:24:35-04:00June 24, 2022|Florida|

Illinois

The HFS (Healthcare and Family Services) Illinois Drugs and Therapeutics Advisory Board’s quarterly meeting will be held on Thursday, July 14, 2022. Call in information can be found here. Pre-registration is required. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-06-24T12:23:59-04:00June 24, 2022|Illinois|

Iowa

On June 13, Gov. Kim Reynolds (R) signed HF 2384 related to PBMs (Pharmacy Benefit Managers) including MAC (Maximum Allowable Cost) lists, claw backs and enforcement.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-06-24T12:23:24-04:00June 24, 2022|Iowa|

Minnesota

MDH (Minnesota Department of Health) has updated the Interim COVID-19 Vaccine Provider Guide, Template: COVID-19 Screening and Agreement and created the Pfizer-BioNTech COVID-19 Vaccine Protocol for 6 months through 4 years and Moderna COVID-19 Vaccine Protocol for 6 months through 5 years. Find these resources at COVID-19 Vaccine Providers.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-06-24T12:22:29-04:00June 24, 2022|Minnesota|

New Jersey

This week at the New Jersey Board of Pharmacy, the Board agreed to extend the remote processing pilot program for 6 months to allow time for the regulations to be finalized. The Board will be notifying New Jersey pharmacies of this extension. Today there are 124 pilot programs up and running. NACDS sent a letter last month requesting that the pilot be continued. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-06-24T12:22:02-04:00June 24, 2022|New Jersey|

Ohio

Last week, Medicaid (ODM (Ohio Department of Medicaid)) held a pharmacy stakeholders’ online seminar where they announced pharmacy reimbursement rates under the Single PBM, “Next Generation of Managed Care Program.” The slides and a recording of the online seminar can be found on the SBPM website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-06-24T12:21:27-04:00June 24, 2022|Ohio|

Pennsylvania

Legislation that would allow pharmacists and pharmacy interns to administer COVID and flu vaccines to children down to the age of 5 advanced in both Chambers this week. HB (House Bill) 2679 was reported from the House Professional Licensure Committee and is poised for a vote by the full House next week. The Senate Professional Licensure Committee also amended SB (Senate Bill) 511 to match the language in HB 2679 and unanimously reported it to the full Senate for consideration. The intent is to deliver one of these bills to the Governor’s desk before adjournment for summer recess. However, if the General Assembly adjourns early, we are optimistic that the process can be completed in the fall, prior to sine die.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-06-24T12:20:41-04:00June 24, 2022|Pennsylvania|

Texas

In advance of the House and Senate health committee interim hearings this summer studying the pandemic response, NACDS and our in-state partner, the Texas Federation of Drug Stores (TFDS) provided joint letters to both the Senate Health and Human Services Committee and the House Select Committee on Health Care Reform highlighting how Texas pharmacies, empowered through federal authorizations to expand access to essential care services, were instrumental in providing millions of vaccinations, tests, and access points for antivirals. We urged lawmakers to take action to maintain critical access to care at pharmacies, allowing pharmacies/pharmacists to order and administer vaccinations approved by CDC/ACIP for ages 3 and older; initiate corresponding treatment pursuant to the result of a CLIA (Clinical Laboratory Improvement Amendments)– waived test; and permit pharmacy technicians’ to also administer the tests and vaccines. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-06-24T12:20:08-04:00June 24, 2022|Texas|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top